Navigation Links
Big Arrow Group Expands Global Capabilities with Addition of Anne de Schweinitz
Date:2/12/2009

NEW YORK, Feb. 12 /PRNewswire/ -- Big Arrow Group, a New York-based full-service strategic consulting and communications firm, today announced that Anne de Schweinitz has joined the company.

As a member of Big Arrow's leadership team, Ms. de Schweinitz will be responsible for driving business growth by ensuring the success of current client programs and by expanding Big Arrow's offerings and expertise, especially in the area of global pharmaceutical and healthcare consulting.

Ms. de Schweinitz brings deep experience in healthcare marketing and communications to Big Arrow Group. She joins the firm following nearly 10 years at MS&L, a global communications agency within the Publicis Groupe of companies, where she served most recently as senior vice president and global account director for the agency's largest healthcare client, Eli Lilly and Company. In addition to overseeing teams in North American and Europe working in the areas of diabetes, cardiovascular disease, women's health and erectile dysfunction, Anne worked closely with Lilly's U.S. and global brand teams to help align and reposition the company's broad offering in diabetes.

"Success as a global account director for major companies and brands, especially in highly regulated industries, requires exceptional strategic insight and creative savvy. Anne has built an excellent reputation as a trusted advisor to her clients, helping them address their most critical business needs through highly differentiated and influential communications programs," said Mike Marino, president and founder of Big Arrow Group.

Prior to joining MS&L's New York office in 2006, Ms. de Schweinitz held positions in San Francisco and London, where she led the agency's global accounts for sanofi-aventis as well as programs on behalf of numerous pharmaceutical, biotech, medical device and healthcare delivery companies in a wide range of therapeutic ar
'/>"/>

SOURCE Big Arrow Group
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
3. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
4. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
5. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
6. Arrow International Announces Annual Meeting Voting Results
7. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
9. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
10. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
11. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ewswire-USNewswire/ -- Results of a large-scale cl... of the Radiological Society of North America (RSN...t of annual screening ultrasound for women with de...ncer. In addition, the study confirmed that MRI is.... ,, "We found that annual screening with ultra...
(Date:12/2/2009)...sound of suspicious areas of the breast, including...ernative to invasive biopsies for women under age ...nted today at the annual meeting of the Radiologic...ming high-quality breast ultrasound, we can reduce...agnostic procedures in young women," said senior a...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Global In Vitro Diagnostics Mark...ww.reportlinker.com/p0166596/Global-In-Vitro-Diagn... ,, Global In Vitro Diagnostics Market Analysis...lData,s "Global In Vitro Diagnostics (IVD) Market ...
(Date:12/1/2009)...RNewswire-USNewswire/ -- The Kerlan Jobe Orthopaed..., has agreed to pay the United States $3 million t...backs from HealthSouth Corporation, the Justice De...t resolves allegations that HealthSouth paid kickb...ants, donations to the Kerlan Jobe Foundation, loa...
(Date:12/1/2009)... common but more easily identified, study finds ,... magnetic resonance imaging test is highly effecti...ication called placenta accreta, researchers repor...rounding a fetus attaches too deeply to a woman,s ... parts of the uterine wall, rupturing blood vessel...
Breaking Medicine News(10 mins):Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 14Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 15Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 16Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 17Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 18Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 19Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 20Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 21Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Serious Pregnancy Complication Detected With MRI 2
...ican College of Allergy,Asthma & Immunology (ACAAI...merica surveys that highlight the importance of im...These survey findings and other important,informat...driving the dialogue about unmet needs for patient...
... 22 Medco Health,Solutions, Inc., (NYSE: MHS ) t...dHealth Group to provide pharmacy benefit services...ext generation of collaboration with,UnitedHealth ...p and includes new terms that provide clear alignm...
... To enhance absorption, the,Longevinex(R) matrix ...resveratrol, microencapsulated in an envelope of a... resveratrol in its trans-resveratrol form,from de...resveratrol matrix withstands direct,exposure to s...
...ERTIFICATION PROGRAM CONTINUES TO EXPAND IN THE ... April 22 More people than ever,before are buying...,standards -- especially people with asthma and al...ts and finishes from manufacturing or,packaging, a...
...onal Union files anti-SLAPP motion against,the Cal... vacate TRO,publicity stunt, OAKLAND, Calif., Apr...SEIU) today filed an anti-Strategic Lawsuit,to Pre...ivisive tactics. The motion cites a temporary rest...
...Jury Endorses Competition in the Durable Medical ...TTLE, April 21 Seattle law firm Williams Kastner,...ay in a business,litigation case involving claims ...man, Warren and Ruth Ann Hall and Halls,Drug Cente...
Other Medicine News:Health News:Medco, UnitedHealth Group Announce Pharmacy Services Agreement 2Health News:New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation 2Health News:More Americans are Sleeping Thanks to Science 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 3Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 4
(Date:12/2/2009)..., EAST HANOVER, N.J., Dec. 2 Nova...te-breaking presentation on Tasigna® (nilotin...eukemia, demonstrate the strength of the company,s...ients. ,, The new data, at the 51st American S...sition, highlight the company,s current therapies ...
(Date:12/1/2009)...ULA, Calif., Dec. 1 Pati... PSTX) announced today that it has appointed Marc ...al Officer, Treasurer and Corporate Secretary, rep...2008. Prior to joining Patient Safety Technologie...f Financial Officer, Treasurer and Corporate Secre...
(Date:12/1/2009)...O BEACH, Calif., Dec. 1 Reproducti...ective Single Embryo Transfer (eSET) Encouragement...ents with good embryo quality and a good prognosis...ins by transferring a single embryo. ,, The big...ay is reducing the number of multiple pregnancies,...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology 12472 1Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology 12472 2Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 21 in 4 nursing home residents carry MRSA 47915 11 in 4 nursing home residents carry MRSA 47915 2
... Biotech (OMX Nordic: ACTI),has presented pre-clin...ongress on Inflammation (<a target="_blank" href=,...2007.dk ) held,in Copenhagen June 16-20*. , "The r... of,57-57 for the treatment of SLE and show the po...clinical trials are planned to be,initiated before...
...--Jun 19, 2007 - Geron,Corporation (Nasdaq: GERN) ...ble production, survival following engraftment and...rats was presented,today for GRNCM1, the company,s...c for heart failure, at the International,Society ...airns,Australia., The presentation was one of sev...
Other Medicine Technology:Active Biotech presents new pre-clinical data for the 57-57 project,at the 8th World Congress on Inflammation 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6
Lerman Shoulder
Ultra Shoulder Abduction Pillow w/Sling
Shoulder Subluxation Inhibitor (SSI)
Comfor™ Clavicle Brace - Buckle Closure
Medicine Products: